5HT3 receptor antagonists
What are 5HT3 receptor antagonists?
5-HT3 receptor antagonists (also called serotonin receptor antagonists or serotonin blockers) are a class of medicines that are used for the prevention and treatment of nausea and vomiting, particularly that caused by chemotherapy, radiation therapy, or postoperatively. 5-HT3 is an abbreviation for serotonin that may also be written as 5-hydroxytryptamine.
Cells lining the gastrointestinal tract release serotonin when damaged by chemotherapy and radiation therapy. This serotonin binds to serotonin receptors on nerves that transmit impulses to the vomiting center within the brain, which in turn stimulates other nerves involved in the vomit reflex. 5-HT3 receptor antagonists prevent serotonin from binding to 5-HT3 receptors in the small intestine thereby reducing the likelihood of nausea and vomiting. The way 5-HT3 receptor antagonists work to prevent postoperative nausea and vomiting is less well understood.
The first generation 5-HT3 receptor antagonists include dolasetron, granisetron, and ondansetron. Despite variations in their chemical structures and absorption rates, they all work in the same way and are well tolerated. The oral formulations are just as effective at preventing nausea and vomiting as the intravenous forms.
Palonosetron is a second-generation serotonin blocker. It has a greater affinity for serotonin receptors than first generation agents, which increases its duration of effect. Palonosetron is also thought to have an effect on 5-HT3 receptors in the vomiting center and chemoreceptor trigger zone as well, not just the small intestine. It is approved for both acute and delayed chemotherapy-induced nausea and vomiting.
List drug with 5HT3 receptor antagonists
Drug Name |
---|
Aloxi Generic name: Palonosetron (injection) |
Anzemet Generic name: Dolasetron (oral) |
Anzemet (Dolasetron Intravenous) Generic name: Dolasetron |
Anzemet (Dolasetron Oral) Generic name: Dolasetron |
Dolasetron Generic name: Dolasetron (oral) |
Dolasetron (Intravenous) Generic name: Dolasetron |
Dolasetron (Oral) Generic name: Dolasetron |
Granisetron Generic name: Granisetron (oral) |
Granisetron (Intravenous) Generic name: Granisetron |
Granisetron injection Generic name: Granisetron (injection) |
Granisetron transdermal Generic name: Granisetron (transdermal) |
Kytril Generic name: Granisetron (oral) |
Ondansetron Generic name: Ondansetron (oral) |
Ondansetron (Oral, Oromucosal) Generic name: Ondansetron |
Ondansetron injection Generic name: Ondansetron (injection) |
Palonosetron Generic name: Palonosetron |
Palonosetron injection Generic name: Palonosetron (injection) |
Sancuso Generic name: Granisetron (transdermal) |
Sustol injection Generic name: Granisetron (injection) |
Zofran Generic name: Ondansetron (oral) |
Zofran (Ondansetron Injection) Generic name: Ondansetron |
Zofran (Ondansetron Oral, Oromucosal) Generic name: Ondansetron |
Zofran injection Generic name: Ondansetron (injection) |
Zofran ODT Generic name: Ondansetron (oral) |
Zuplenz Generic name: Ondansetron (oral) |
Disclaimer
Every effort has been made to ensure that the information provided by Drugslib.com is accurate, up-to-date, and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. Drugslib.com information has been compiled for use by healthcare practitioners and consumers in the United States and therefore Drugslib.com does not warrant that uses outside of the United States are appropriate, unless specifically indicated otherwise. Drugslib.com's drug information does not endorse drugs, diagnose patients or recommend therapy. Drugslib.com's drug information is an informational resource designed to assist licensed healthcare practitioners in caring for their patients and/or to serve consumers viewing this service as a supplement to, and not a substitute for, the expertise, skill, knowledge and judgment of healthcare practitioners.
The absence of a warning for a given drug or drug combination in no way should be construed to indicate that the drug or drug combination is safe, effective or appropriate for any given patient. Drugslib.com does not assume any responsibility for any aspect of healthcare administered with the aid of information Drugslib.com provides. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.
Popular Keywords
- metformin obat apa
- alahan panjang
- glimepiride obat apa
- takikardia adalah
- erau ernie
- pradiabetes
- besar88
- atrofi adalah
- kutu anjing
- trakeostomi
- mayzent pi
- enbrel auto injector not working
- enbrel interactions
- lenvima life expectancy
- leqvio pi
- what is lenvima
- lenvima pi
- empagliflozin-linagliptin
- encourage foundation for enbrel
- qulipta drug interactions